JP Morgan Chase
PASW

JP Morgan Chase’s Ping An Biomedical PASW Stock Holding History

JP Morgan Chase’s Portfolio PASW Stock Details PASW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42
Closed -$52 – 7927
2025
Q3 		$52 Buy
+42
New +$62 ﹤0.01% 7219

Other funds holding PASW

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's PASW Position: Q4 2025 in Review

JP Morgan Chase sold out of Ping An Biomedical (PASW) in Q4 2025, closing a stake of 42 shares — an estimated $52 sold.

JP Morgan Chase first reported a position in PASW in Q3 2025 and held it in 1 quarter. The position peaked at $52 in Q3 2025. 3 funds tracked by Wall St. Rank hold PASW as of Q4 2025.

  • JP Morgan Chase reported no remaining Ping An Biomedical position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 42 Ping An Biomedical shares in Q4 2025, an estimated $52.
  • JP Morgan Chase first reported a position in Ping An Biomedical in Q3 2025 and held it in 1 quarter.
  • JP Morgan Chase's Ping An Biomedical position peaked at $52 in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Ping An Biomedical as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.